In July, New York City Comptroller Brad Lander, a self-proclaimed “member of the Planned Parenthood family,” warned pharmacy chains that if they didn’t begin dispensing the abortion pill regimen, they should expect to suffer financially. Now, Live Action News has obtained response letters from various pharmacy chains, written in reply to Lander’s demand letters.
These response letters suggest that Walmart and Kroger may be considering a move toward dispensing the abortion pill mifepristone.
The letters, detailed below, were sent to Live Action News in response to a Freedom of Information Request (FOIA), indicating that Walmart plans to “evaluate the requirements related to dispensing mifepristone in our pharmacies.” Kroger claimed the company has begun “a review of the federal certification process.” McKesson responded by e-mail to Lander’s demand, but that corporation’s correspondence (see below) was less clear.
Pharmacy chains Walgreens and CVS previously announced that they finalized the pharmacy dispensing certification process this past spring. Additional “certified pharmacies” who agreed to be publicly named have been published on GenBioPro’s website.
NYC Comptroller Letter
In January 2023, the FDA announced its decision to roll back REMS safety regulations and allow retail pharmacies to dispense the abortion drug mifepristone (Mifeprex) after completing a certification process. The drug is reportedly distributed to pharmacies by AmerisourceBergen (recently renamed Cencora), one of the largest pharmaceutical distribution companies in the world. […]
— Read More: www.liveaction.org
